Samples (0.25 mL) were incubated at 37 °C with vigorous stirring in Dabrafenib datasheet 18-mL flasks. For the DCCD control, samples were preincubated with 100 μM DCCD at room temperature for 30 min. The reaction was initiated with 5 mM succinate. After 2 h, each reaction was stopped with 25 mM EDTA, followed by transfer to ice. Samples were transferred to Eppendorf tubes, boiled for 5 min and centrifuged (10 000

×g, 20 min) to remove denatured protein. In the supernatants, the synthesized glucose-6-phosphate was oxidized by 2.5 mM NADP in the presence of 3 U mL−1 of glucose-6-phosphate dehydrogenase (Roche). NADPH formation was monitored using a spectrophotometer at 340 nm. ATP hydrolysis activity was measured by quantifying the amount of phosphate released (Bell & Doisy, 1920). IMVs (0.5 mg mL−1) Omipalisib solubility dmso from M. bovis BCG or M. smegmatis were incubated in 10 mM HEPES-KOH (pH 7.5), 100 mM KCl, 5 mM MgCl2 at 37 °C. For the DCCD control, samples were preincubated with 100 μM DCCD at room temperature for 30 min. The reaction was initiated by 2 mM ATP. After 30 min, the reaction was quenched by the addition of 2.4% (w/v) trichloroacetic

acid and the membranes were pelleted by centrifugation at 20 800 g and 4 °C for 15 min. Activation by methanol: IMVs (0.5 mg mL−1) were incubated with 17% or 25% methanol. ATP hydrolysis was assayed as described earlier. Activation by PMF: IMVs (2.5 mg mL−1) were incubated in the presence of 10 mM succinate to establish a PMF at 37 °C for 10 min. A mixture of malonate and ATP (final concentrations

are, respectively, 50 and 2 mM) was added and the incubation was quenched by the addition of 2.4% (w/v) trichloroacetic acid after 2.5 min. ATP hydrolysis was assayed as described earlier. Activation by trypsin: IMVs (0.5 mg mL−1) were incubated with trypsin at 30 °C for 10 min. Mycobacterium bovis BCG was treated with 90 or 750 U mL−1 of trypsin, while M. smegmatis was treated with 90 U mL−1 of trypsin. The reaction was terminated by the addition of trypsin inhibitor (1.5 mg of inhibitor per 1.0 mg of trypsin). ATP hydrolysis assay was performed as described earlier. Activation by sulfite: IMVs (0.5 mg mL−1) were incubated with 10 mM sodium sulfite. ATP hydrolysis was assayed as described earlier. To investigate the role of mycobacterial ATP synthase, we prepared functionally coupled IMVs from the slow-growing M. bovis BCG. This strain 3-oxoacyl-(acyl-carrier-protein) reductase shares >99.9% DNA sequence identity with M. tuberculosis and strongly resembles M. tuberculosis in terms of sensitivity to diarylquinolines (Mattow et al., 2001; Huitric et al., 2007). For comparison, we carried out the same set of experiments with the fast-growing saprophyte M. smegmatis. To cope with the extremely thick cell envelope of M. bovis BCG, we optimized the preparation of IMVs in terms of the time and temperature of cell envelope digestion by lysozyme, number of French Press passages and subsequent centrifugation steps (cf. Materials and methods).